Skip to main content
. 2015 Apr 17;7:213–225. doi: 10.2147/CEOR.S78115

Table 3.

Expected cost breakdown under the base-case scenario (deterministic results)

Type of costs Ulipristal Leuprolide Difference (ie, ulipristal – leuprolide)
Drug-related costs ($)
 Drug costs 1,113.91 1,124.86 -10.95
 Pharmacist dispensation 8.40 25.20 -16.80
 Drug administration 0.00 113.44 -113.44
Total drugs 1,122.31 1,263.50 -141.19
Non-drug costs
 Medical visits* 149.15 101.7 47.45
Total direct health care costs 1,271.46 1,365.20 -93.74
Cost from time lost from work due to symptoms 66.13 93.23 -27.10
Cost from time lost from work due to medical visits 78.68 157.35 -78.67
Total indirect health care costs 144.81 250.58 -105.77

Notes:

*

Medical visits in which patients are assessed by the physician and receive an injection are not captured here. Rather, such costs have been classified under “drug administration”. Costs in 2013 Canadian dollars.